发明名称 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
摘要 This invention is directed to the (S)-enantiomer of the compound of formula (I):; or a pharmaceutically acceptable solvate or prodrug thereof. This (S)-enantiomer is useful for the treatment of diseases or conditions, such as pain, which are ameliorated or alleviated by the modulation of voltage-gated sodium channels.
申请公布号 US9480677(B2) 申请公布日期 2016.11.01
申请号 US201414510634 申请日期 2014.10.09
申请人 Xenon Pharmaceuticals Inc. 发明人 Chafeev Mikhail;Fu Jianmin;Cadieux Jean-Jacques Alexandre
分类号 A61K31/407;C07D491/22;C07D491/20 主分类号 A61K31/407
代理机构 Seed IP Law Group LLP 代理人 Seed IP Law Group LLP
主权项 1. A method of treating familial erythromelalgia and primary erythromelalgia in a mammal by the inhibition of ion flux through a voltage-gated sodium channel in the mammal, wherein the method comprises administering to the mammal in need thereof a therapeutically effective amount of the (S)-enantiomer of 1′-{[5-(trifluoromethyl)furan-2-yl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3′-indol]-2′(1′H)-one having the following formula (I-S): or a pharmaceutically acceptable solvate or prodrug thereof.
地址 Burnaby, BC CA